Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
1,395,159
-
Shares change
-
+395,085
-
Total reported value, excl. options
-
$1,892,542
-
Value change
-
+$537,844
-
Number of buys
-
19
-
Number of sells
-
-2
-
Price
-
$1.36
Significant Holders of MIRA PHARMACEUTICALS, INC. - COM (MIRA) as of Q3 2025
30 filings reported holding MIRA - MIRA PHARMACEUTICALS, INC. - COM as of Q3 2025.
MIRA PHARMACEUTICALS, INC. - COM (MIRA) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,395,159 shares
.
Largest 10 shareholders include Cross Staff Investments Inc (359,401 shares), VANGUARD GROUP INC (203,643 shares), GEODE CAPITAL MANAGEMENT, LLC (136,440 shares), BlackRock, Inc. (109,769 shares), Suncoast Equity Management (103,289 shares), FIRST AMERICAN BANK (50,000 shares), STATE STREET CORP (49,100 shares), RENAISSANCE TECHNOLOGIES LLC (46,700 shares), TWO SIGMA INVESTMENTS, LP (45,703 shares), and J.W. COLE ADVISORS, INC. (45,501 shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.